Organigram to buy Aurora Cannabis for C$561 million, topping Curaleaf's approach
InsideArbitrage · · AI-summarised by FinFlash
Organigram Global agreed to acquire Aurora Cannabis for C$561 million, or about $401 million, with holders able to elect C$7.80 cash, 5.8626 Organigram shares, or a mix for each share. The cash price is a 32.23% premium to the last close. Aurora holders would own about 35% of the combined company, and British American Tobacco, with 30% of Organigram's votes, supports the deal. Completion is expected in January 2027.
So What?
Consolidation among Canadian cannabis producers could lift ACB toward the offer terms while dilution may weigh on OGI. Watch for any revised Curaleaf bid.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.